|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Cash and Cash Equivalents | ||||||||||||||||||||
| Accounts Receivable, Net | ||||||||||||||||||||
| Notes Receivable | ||||||||||||||||||||
| Inventory, Net | ||||||||||||||||||||
| Prepaid Expenses | ||||||||||||||||||||
| Other Current Assets | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Property and Equipment, Net | ||||||||||||||||||||
| Other Assets | ||||||||||||||||||||
| Intangible Assets, Net | ||||||||||||||||||||
| Right of Use Asset | ||||||||||||||||||||
| Notes Receivable | ||||||||||||||||||||
| Other Assets | ||||||||||||||||||||
| Total Other Assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities and Stockholders’ Equity | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Accounts Payable and Accrued Expenses | ||||||||||||||||||||
| Loans Payable, Net of Loan Fees | ||||||||||||||||||||
| Right of Use Operating Lease Obligation - Current | ||||||||||||||||||||
| Income Tax Payable | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Long Term Liabilities | ||||||||||||||||||||
| Right of Use Operating Lease Obligation - Long Term | ||||||||||||||||||||
| Total Long-Term Liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Stockholders’ Equity | ||||||||||||||||||||
| Common stock, $.001 par value, 50,000,000 shares authorized 43,979,064 outstanding and issued at June 30, 2026 and 43,979,064 outstanding and issued at December 31, 2025 | ||||||||||||||||||||
| Additional Paid In Capital | ||||||||||||||||||||
| Accumulated Deficit | ||||||||||||||||||||
| Total Stockholders’ Equity | ||||||||||||||||||||
| Total Liabilities and Stockholders’ Equity | ||||||||||||||||||||
Loading...
